New Board of Directors brings extensive experience leading major multinational companies around the world
Predominantly independent directors strengthens shareholder representation and governance requirements of more senior exchanges

DENVER, CO / ACCESSWIRE / January 31, 2017 / New Age Beverages Corporation (OTC PINK: NBEV) the Colorado-based Company that markets the brands XingTea®, Aspen Pure® Rocky Mountain Water, Búcha® Live Kombucha, Marley One Drop® Coffee, and Marley Mellow Mood® Relaxation Drinks, today announced that it has appointed five new independent Board of Directors to strengthen shareholder representation, improve governance and to help guide the strategic direction of the firm through its next phase of the growth and evolution.

Joining the New Age Board are five new Directors including: Ed Brennan, Greg Fea, Tim Haas, Dr. Reginald Kapteyn, and David Vautrin.

Ed Brennan is currently the owner and CEO of Beak and Skiff, a family-owned major apple orchard and beverage production operation in Lafayette, New York. Ed is also the former Chairman and CEO of Duty Free Stores, and the former CMO of Macy’s.

Greg Fea is currently the Managing Partner of Global Solutions Consulting. Greg is also the former Vice-Chairman, CEO, and President of Illy Caffe, a $400 million coffee company with operations across 140 countries. He also led the North American business of Danone, which included the Evian, Volvic and Dannon brands.

Tim Haas is the former Chief Executive Officer of Coca-Cola Foods, the former CEO of The Minute Maid Company, and the former Group President of Coca-Cola Latin America. Following retirement from Coca-Cola in the mid 2000’s, he started an investment management company and been involved in numerous public and private ventures.

Dr. Reginald Kapteyn is business owner and board certified practicing physician at OAM in Michigan where he is also their Director of Pain Management. He is a Director and owner of Vivitris Life Sciences, Inc., and a Director of Product Development at HydroCision, Inc. Dr. Kapteyn is also the former Medical Director at Drake University, and completed his fellowship and is published at the NIH (National Institutes of Health).

David Vautrin is currently the Chief Executive Officer of XFit Brands, Inc. a public company and an advisor to the DeBeukelaer Corporation, maker of Pirouline Cookies. Mr. Vautrin is also the former Chief Marketing Officer of Cott Corporation. Prior to Cott, Mr. Vautrin was the founder and majority owner of Pacific Chai, a Company he later sold to HP Hood.

As part of the appointment of the new Board of Directors, former Directors Julie Anderson and Simon Majumdar have resigned from the Board. Both Ms. Anderson and Mr. Majumdar provided critical leadership in the evolution of the firm from American Brewing to Búcha, Inc. to New Age Beverages. Both Neil Fallon and Brent Willis will remain on the Board, and in their current roles as Executive Chairman and CEO respectively.

Brent David Willis, Chief Executive Officer of New Age Beverages Corporation and a former senior executive with AB InBev and the Coca-Cola Company commented, “We are extremely fortunate to have such an esteemed group of leaders sign up to help guide our Company as we embark on our next phase of growth. They all bring global experience and unique skills within Consumer Goods, Beverages, Retail, and Health Sciences. We are humbled and honored to have them join our Company, and express our sincerest gratitude to Julie Anderson and Simon Majumdar for their loyal and dedicated work during their tenure as Directors.”

About New Age Beverages Corporation (OTC: NBEV)

New Age Beverages Corporation is a Colorado-based, healthy functional beverage company originally founded in 2003 and re-created via the combination of XingTea®, Aspen Pure® Rocky Mountain Water, Búcha® Live Kombucha, and New Age Beverages in June 2016. In October 2016, the Company signed a management agreement to take over the Marley One Drop® RTD Coffee, and Marley Mellow Mood™ Relaxation Drinks brands. The Company trades under the symbol NBEV on the OTC exchange. The Company competes in the fast growing healthy functional beverage segments including Ready to Drink (RTD) Tea, RTD Coffee, Kombucha, Energy Drinks, Relaxation Drinks and Functional Waters. The Company’s brands are sold across all 50 states within the US and in more than 10 countries internationally across all channels via direct and store door distribution systems. The company operates the websites www.newagebev.us, www.mybucha.com, www.xingtea.com, www.aspenpure.com, and www.drinkmarley.com.

Safe Harbor Disclosure

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are any statement reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company including statements regarding New Age Beverage’s expectation to see continued growth. The forward-looking statements are based on the assumption that operating performance and results will continue in line with historical results. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. New Age Beverages competes in a rapidly growing and transforming industry, and other factors disclosed in the Company’s filings with the Securities and Exchange Commission might affect the Company’s operations. Unless required by applicable law, New Age Beverages undertakes no obligation to update or revise any forward-looking statements.

For investor inquiries about New Age Beverages Corporation please contact:

Amato and Partners, LLC
Investor Relations Counsel
admin@amatoandpartners.com

Websites: www.newagebev.us
www.mybucha.com
www.xingtea.com
www.aspenpure.com
www.drinkmarley.com

SOURCE: New Age Beverages Corporation

ReleaseID: 453914

DALLAS, TX / ACCESSWIRE / January 31, 2017 / Puration, Inc. (OTC PINK: PURA) and North American Cannabis Holdings, Inc. (OTC PINK: USMJ), commonly known by its U-S-M-J ticker symbol, today announced a new website dedicated to the coming official launch of EVERx CBD Infused Bottled Water. EVERx is a new sports, fitness and wellness nutritional supplement brand specializing in products infused with cannabidiol (CBD). Puration licensed from USMJ the rights to develop and market a CBD infused water. EVERx CBD Infused Bottled Water is the first EVERx brand commercial launch. On Thursday, February 2nd, 2017 an official EVERx CBD Infused Bottled Water product launch event scheduled to take place at a major industry trade show in March will be announced.

Details about the EVERx CBD Infused Bottle Water product launch will be available at the link below:

WWW.DRINKEVERx.COM

To learn more about North American Cannabis Holdings: growusmj.com.
Follow the Company on Twitter: US_HEMP

To learn more about Puration: purationinc.com
Follow Puration on Twitter: Puration710
Visit Puration on Facebook: Facebook.com/puration/

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

North American Cannabis Holdings Contact:

Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com

Puration Contact:

Brian Shibley, CEO
info@purationinc.com
+1-214-937-9097

SOURCE: Puration

ReleaseID: 453941

VANCOUVER, BC / ACCESSWIRE / January 31, 2017 / Bearing Resources Ltd. (TSXV: BRZ) (“Bearing” or the “Company”) is pleased to announce, with Li3 Energy Inc. (“Li3”), that on January 27, 2017 they entered into an agreement and plan of merger (the “Agreement”) under which Bearing has agreed to acquire Li3.

Pursuant to the Agreement, a newly-formed wholly owned subsidiary of Bearing will merge with and into Li3 (the “Merger”), with Li3 surviving the Merger as a wholly owned subsidiary of Bearing. At the effective time of the Merger, each share of Li3 common stock will be converted into the right to receive common shares of Bearing based upon an aggregate of 16 million Bearing common shares issuable for the Li3 common stock.

As a result, the approximately 16 million common shares of Bearing that the Li3 stockholders will receive will represent approximately 43% of the issued and outstanding shares and voting power of the combined company after giving effect to the Merger. Holders of options and warrants to purchase Li3 common stock will receive options and warrants to purchase common shares of Bearing in exchange for their Li3 options and warrants, as adjusted based on the exchange ratio of Li3 common stock to Bearing common stock in the Merger, but otherwise on the same terms and conditions as in the original Li3 options and warrants.

Jeremy Poirier, the President of Bearing, stated: “We are excited to finalize our agreement with Li3 Energy. Now that this important step has been completed we can focus on closing the transaction while we work with our new partners to move this world class project forward.”

In addition, Patrick Cussen, Chairman of the Board of Li3 Energy commented: “This is an important step for Li3 and its shareholders. It is an exciting time for lithium and particularly in Chile. Our Maricunga project has been advancing well on the current exploration program. It is the most advanced development project in Chile and showing very good exploration results. We look forward to working with the Bearing team and our partners to advance this world class project.”

Bearing’s Agreement with Li3 Energy Inc. will enable it to acquire an interest in an advanced advanced-stage Maricunga project located in Chile (the “Maricunga Project”), which represents one of the highest-grade development opportunities in the Americas. Assuming completion of the transactions contemplated by the Agreement, Bearing will have an undivided 17.7% interest in the project with all expenditures through to the delivery of a Definitive Feasibility Study (DFS) fully-funded by its joint-venture partners. The Maricunga Project has had in excess of US$25 million of exploration to date. Bearing currently holds a portfolio of prospective, grass-roots exploration projects in gold district of the Yukon near Golden Predator.

The transactions are subject to customary closing conditions, including the approval of the TSX Venture Exchange and of the shareholders of Li3 and, if required, of Bearing.

Key Transaction Details

Li3 will file a Current Report on Form 8-K with the U.S. Securities and Exchange Commission (the “Current Report”) and Bearing will file a Material Change Report with the Canadian Securities Commissions (the “Material Change Report”), in each case with respect to the Merger. The Current Report will be available for review at www.sec.gov, and the Material Change Report will be available for review at www.sedar.com. The information in this press release is qualified in its entirety by reference to the Current Report, the Material Change Report and the Agreement included as an exhibit to such reports.

Advisors

Macdonald Tuskey served as legal counsel to Bearing, and Ellenoff Grossman & Schole LLP served as Li3’s legal counsel.

ON BEHALF OF THE BOARD

Signed “Jeremy Poirier”

Jeremy Poirier, Director President and CEO

FOR FURTHER INFORMATION PLEASE CONTACT:

Jeremy Poirier
President and CEO Bearing Resources – Telephone: 1- 604-262-8835

The Merger cannot close until all of the conditions have been satisfied and there can be no certainty that the Merger will be completed, either as presently proposed, or at all.

Important Information For Investors And Stockholders

This communication does not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. This communication relates to a proposed business combination between Li3 Energy, Inc. (“Li3”) and Bearing Resources Ltd. (“Bearing”). In connection with this proposed business combination, Li3 and/or Bearing will file relevant materials with the Securities Exchange Commission (the “SEC”) and applicable Canadian securities regulatory authorities (“Canadian Securities Commissions”), including a Bearing registration statement on Form F-4 or S-4 that will include a proxy statement of Li3 and constitute a prospectus of Bearing. INVESTORS AND SECURITY HOLDERS OF Li3 AND BEARING ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT MAY BE FILED WITH THE SEC AND THE CANADIAN SECURITIES COMMISSIONS CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Any definitive proxy statement (if and when available) will be mailed to stockholders of Li3. Investors and security holders will be able to obtain free copies of these documents (if and when available) and other documents filed with the SEC by Li3 and/or Bearing through the website maintained by the SEC at www.sec.gov and, in the case of documents of Bearing filed with the Canadian Securities Commissions, on Bearing’s SEDAR profile on www.sedar.com. Copies of the documents filed with the SEC by Li3 will be available free of charge on Li3’s website at www.li3energy.com or by contacting Li3’s Investor Relations Department by email info@li3energy.com. Copies of the documents filed with the SEC and the Canadian Securities Commissions by Bearing will be available free of charge on Bearing’s website at www.bearingresources.ca or by contacting Bearing’s Investor Relations Department by email at Skoyich@briscocapital.com or by phone at (403) 619-2200.

Participants in the Merger

Li3, Bearing, and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of Li3 in connection with the Merger. Information regarding the officers and directors of Li3 is set forth in Li3’s annual report on Form 10-K for the year ended June 30, 2016, which was filed with the SEC on October 7, 2016. Additional information regarding the interests of such potential participants will also be included in the registration statement on Form F4 or S-4 (and will be included in the definitive proxy statement/prospectus for the Merger) and other relevant documents filed with the SEC.

Cautionary Statement on Forward-looking Information

Certain statements in this news release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation (collectively, “forward-looking statements”) that may not be based on historical fact, but instead relate to future events, including without limitation statements containing the words “believe”, “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect” and similar expressions. All statements other than statements of historical fact included in this release are forward-looking statements, including statements regarding: the ability of Bearing and Li3 to consummate the transactions contemplated by the Agreement; the anticipated benefits of the transactions contemplated by the Agreement, including the Merger; and statements regarding the operation of each of Li3 and Bearing’s businesses, including the interest in mineral properties to be acquired by virtue of the Merger.

Such forward-looking statements are based on a number of assumptions, including assumptions regarding the ability of the parties to satisfy, in a timely manner, the conditions contained in the Agreement; the successful development and/or commercialization of Li3 and Bearing’s respective products, including the receipt of necessary regulatory approvals; general economic conditions; that the parties’ respective businesses are able to operate as anticipated without interruptions; competitive conditions; and changes in laws, rules and regulations applicable to Li3 and Bearing. Although management of Li3 and Bearing believe that the assumptions made and expectations represented by such statements are reasonable, there can be no assurance that a forward-looking statement contained herein will prove to be accurate. Actual results and developments may differ materially from those expressed or implied by the forward-looking statements contained herein and even if such actual results and developments are realized or substantially realized, there can be no assurance that they will have the expected consequences or effects. Factors which could cause actual results to differ materially from current expectations include: non-completion of the transactions contemplated by the Agreement, including due to the parties failing to receive the necessary shareholder, stock exchange and regulatory approvals or the inability of the parties to satisfy in a timely manner and on satisfactory terms the necessary conditions; the failure to successfully develop or commercialize the parties’ respective products; adverse changes in general economic conditions or applicable laws, rules and regulations; and other factors detailed from time to time in each of Li3 and Bearing’s periodic disclosure. Given these risks, uncertainties and factors, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based on the parties’ current expectations and neither party undertakes an obligation to revise or update such forward looking statements and information to reflect subsequent events or circumstances, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Bearing Resources Ltd.

ReleaseID: 453940

ZURICH, SWITZERLAND / ACCESSWIRE / January 31, 2017 / The first 2017 edition of the German print magazine Derivate Magazine includes the readworthy article “Edelmetalle 2017: Zwischen Glaskugel und Kaffeesatz”, in which living legends of the financial sector discuss price performance potentials of precious metals going forward. Alongside the precious metals producers Endeavour Silver (Mexico) and Sibanye Gold (Africa), Golden Dawn Minerals Inc. (TSX.V: GOM) is being presented as a promising investment candidate.

Leo Nelissen explained in a new article, why gold and gold mining stocks are “the best hedge against possible disappointments from the high expectations regarding Trump´s policies and actions”. He also believes that gold can do well even if Trump doesn´t disappoint. On top of that, Nelissen says that gold miners seem to be the best hedge against a general market correction, during which times gold stocks should perform well. As the USD futures traders are very bullish at the moment, any disappointments could push the USD much lower. “This would mean another massive gold (miners) rally”, he concluded.

The full report can be accessed with the following links:

English (web version): http://rockstone-research.com/index.php/en/markets-commodities/2399-Gold-and-Gold-Stocks:-The-Best-Hedge-Against-Trump-and-Other-Uncertainties

German (web version): http://rockstone-research.com/index.php/de/maerkte-rohstoffe/2395-Gold-und-Goldminenaktien-sind-die-beste-Absicherung-gegen-Trump-und-andere-Ungewissheiten

German (PDF): http://rockstone-research.com/images/PDF/GoldenDawn12de.pdf

Disclaimer: Please read the full disclaimer within the full research report as a PDF as fundamental risks and conflicts of interest exist.

SOURCE: Rockstone Research

ReleaseID: 453938

COSTA MESA, CA / ACCESSWIRE / January 31, 2017 / NEMUS Bioscience, Inc. (OTCQB: NMUS) announced that the company has signed a research agreement with the University of Mississippi (UM) to further explore the analgesic and abuse-deterrent properties of NB2111, a unique analogue of cannabidiol (CBD). We expect that these planned in vivo studies will serve to complement and expand upon early data that showed NB2111 provided dose-dependent analgesia comparable to opioids in animals exposed to noxious stimuli. NB2111 also exhibited anti-addictive activity against opioids in a validated animal model of abuse liability.

Brian Murphy, M.D., M.B.A., Nemus CEO and Chief Medical Officer, noted, “The global need for effective analgesics continues to grow with aging populations and the attendant conditions associated with diseases of old age. With research indicating a global pain management market potentially growing to $83 billion by 2024 (Transparency Market Research, 2016), Nemus plans to utilize its portfolio of cannabinoid-based therapies to develop a continuum of care for patients experiencing acute or chronic pain, as well as helping patients who may have developed an addiction to opioids convert to cannabinoid-class compounds that we believe offer analgesic coverage without the associated serious adverse safety profile associated with long-term opioid use.”

“According to the Centers for Disease Control (CDC), an average of 78 opioid-related overdose deaths occur each day in the United States while 650,000 opioid prescriptions are dispensed,” commented Dr. Kenneth J. Sufka, professor of Psychology and Pharmacology and Research Professor with the National Center for Natural Products Research at UM. “The opioid epidemic has reached extreme proportions and we feel having a safer yet effective alternative is vital to both national and global health. We believe these compounds will have utility in managing a spectrum of pain conditions, from the quality-of-life debilitating pain associated with fibromyalgia to intense post-surgical pain. Our team looks forward to working with Nemus to explore a variety of treatment options in anticipation of future human studies.”

“The company is happy to work with Professor Sufka, a recipient of the 2014 CASE-Carnegie Award as one of the pre-eminent educator-researchers in the country,” stated Dr. Murphy. “We expect to formally present this data at an upcoming peer-reviewed scientific meeting. Nemus plans to examine developmental partnering opportunities with companies who may already have a presence in this therapeutic area but are looking to expand their portfolio into cannabinoids and/or companies developing novel delivery systems, especially those that permit bypassing first-pass metabolism in the liver.”

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements, including statements about the studies relating to and the potential benefits of NB2111, as well as the timing of our near term, intermediate term, and long term goals. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including “goal,” “focus,” “aims,” “expects,” “plans,” “believes,” “can,” “could,” “challenge,” “predictable,” “will,” or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of NEMUS’s most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, NEMUS disclaims any intent or obligation to update these forward-looking statements.

ABOUT NEMUS BIOSCIENCE, INC.

The Company is a biopharmaceutical company, headquartered in Costa Mesa, California, focused on the discovery, development, and commercialization of cannabinoid-based therapeutics for significant unmet medical needs in global markets. Utilizing certain proprietary technology licensed from the University of Mississippi, NEMUS is working to develop novel ways to deliver cannabinoid-based drugs for specific indications, with the aim of optimizing the clinical effects of such drugs, while limiting potential adverse events. NEMUS’s strategy is to explore the use of natural and synthetic compounds, alone or in combination with partners. The Company is led by a highly qualified team of executives with decades of biopharmaceutical experience and significant background in early-stage drug development.

For more information, visit http://www.nemusbioscience.com.

CONTACTS:

NEMUS Investor Relations
PCG Advisory Group
Adam Holdsworth
Email: adamh@pcgadvisory.com
Phone: 646-862-4607

NEMUS Media Relations
Janet Vasquez
JV Public Relations
Email: jvasquez@jvprny.com
Phone: 212.645.5498

SOURCE: NEMUS Bioscience, Inc.

ReleaseID: 453879

BEND, OR / ACCESSWIRE / January 31, 2017 / Cachet Financial Solutions, Inc. (OTCQB: CAFN) (Cachet Financial or the Company) is a leading FinTech provider of cloud-based, SaaS technology provider, serving the financial services industry with remote deposit capture (RDC), mobile money and prepaid card solutions. Cachet Financial was founded in 2010, and has rapidly grown into a technology leader and trusted partner of some of the world’s largest and most respected financial entities.

Cachet Client Base

Source: Cachet Financial

Market Environment

The average U.S. household has a significant number of recurring bills on a monthly basis, with approximately 24% of U.S. adults not paying their bills on time, according to a 2015 study by the National Foundation for Credit Counseling. Paper-based transactions are expensive and time-consuming for both the biller and customer. As a result, mobile bill payment is becoming a preferred method for transactions, with 33% of U.S. Internet users paying their bills via a mobile device, as reported by eMarketer in March 2016. Significantly, 2015 marked the first time that mobile banking activity exceeded branch banking activity, with 97% of top financial institutions supporting remote deposit capture technology.

Source: Cachet Financial

Cachet Financial’s product services have become an important element in meeting the growing demand of both financial institutions and their customers for mobile banking technology.

Key Components

According to Cachet Financial, their Mobile Money platform is enabled for growth by the following factors:

Current position as a leading provider of innovative prepaid mobile money and remote deposit capture platforms

Vast and growing mobile market opportunity

Award-winning Select Mobile Money mobile platform gaining significant traction in the fast-growing prepaid market

Current position as a trusted provider to 500+ financial services companies, including U.S. Bank, Navy Federal Credit Union, Ceretel, and Simple

Key relationships with Visa, MasterCard, Viamericas, Mitek, and CBKC

Highly scalable soft-as-a-service (SaaS) business model

Record revenue growth and growing pipeline

Management and Board with significant mobile, banking and technology expertise

Solutions

Cachet Financial’s solutions are broken down into 4 categories: Remote Deposit Capture; Mobile Check Payment; Mobile Account Opening; and Prepaid Mobile Platform; providing a do-it-all platform for mobile money needs.

Remote Deposit
Capture

The Company’s remote deposit capture (RDC) platform provides customers to submit images of checks to their financial institution for deposit, and supports PC, Mac and mobile device utilization. Cachet Financial’s RDC platform represents to total solutions for financial services entities, incorporating a proprietary technology to help spot fraud, and supporting audit reporting for compliance requirements, among other features.

Source: Cachet Financial

Mobile Check Payment

Cachet Financial’s mobile check payment platform allows users to scan a check image and submit for payment on loans and other recurring bills. Mobile pay platforms help reduce delinquencies by allowing consumers to make payments at any time, from any location, even at the last minute. In addition to enhancing customers’ experiences, servicing costs are lowered and new fee income is generated for financial service entities.

Mobile Account
Opening

Cachet Financial’s mobile account opening platform provides an alternative to the often cumbersome and time-consuming activity of opening an account at a financial institution. The Company’s platform allows customers to scan their driver’s license, state ID or Passport with their mobile device, with the system documenting and auto populating the required fields. In addition to making the experience more efficient, it reduces the number of errors in the entering of information. With mobile account opening representing 60% of the growth in the number of new accounts between 2013 and 2014, the Company’s mobile account opening technology represents a major improvement to the traditional method of opening an account.

Prepaid Mobile
Platform

The Company’s prepaid mobile platform enables the linking of mobile banking features with prepaid debit cards, allowing users to manage their card accounts and access other financial services. Prepaid cards are attractive to several segments of our society, specifically: Millennials, the Unbanked, and the Underbanked.

Approximately 75.4 million Millennials (ages 18-32) are mobile-savvy and generally don’t care about banks, bank accounts or “human” service

The unbanked are the~16.7 million U.S. adults who have no relationship with a bank or credit union

Underbanked describes those adults with limited banking relationships, estimated at 50.9 million U.S. adults

For those individuals in the segments listed above, prepaid cards are becoming an attractive alternative to traditional banking services, with MasterCard predicting $822 billion in prepaid spend worldwide and a $412 billion U.S. spend in 2017. Cachet Financial is positioned to make money on their prepaid platform by charging upfront implementation and integration fees, along with professional services fees, monthly hosting & maintenance fees, and transaction fees, among others.

Source: Cachet Financial

Summary

Cachet Financial (CAFN) is an established and growing leader in providing mobile financial solutions to the financial services industry. We believe that upon your personal due-diligence, you will agree that the Company’s leadership and innovative technologies have the Company well positioned to capitalize on the rapidly growing mobile money space, making CAFN an attractive investment opportunity.

Disclaimers & Disclosures: For a full list of disclaimers and disclosures, please visit: http://sylvacap.com/disclaimer

Contact: info@sylvacap.com

SOURCE: Sylva International, LLC

ReleaseID: 453888

VANCOUVER, BC / ACCESSWIRE / January 31, 2017 / Enertopia Corporation (OTCQB:ENRT)(CSE:TOP) (the “Company” or “Enertopia”) is pleased to announce it has engaged Peloton AG out of Einsiedeln, Switzerland in property and project procurement.

Pelton AG’s property consultants have been reviewing and vetting South American Lithium projects and Enertopia is appreciative of the hard work the consultants have shown to date. As a result the Board of Enertopia has agreed to grant 1,500,000 options to Pelton AG at $0.07 USD that are valid for 5 years.

The options, which vest immediately and the common shares issuable upon exercise will be subject to applicable regulatory hold periods in the United States and Canada. Also standard success finders fees approved by the CSE may be payable on properties or project financings.

“Enertopia looks forward to receiving the results of the Lithium recovery bench test analysis. We are continuing our ongoing exploration work at our three Nevada Lithium brine projects and continued due diligence in the mineral sector. Modern technology is revolutionizing ways and providing a better way to mine and protect our environment. We are enthusiastic in becoming leaders in this evolution,” stated President and CEO Robert McAllister.

About Enertopia

Enertopia is exploring a portfolio of three prospective lithium projects in Nevada and reviewing other mineral projects, while concurrently working with water purification technology partner GWT using patent pending technology that is believed able to recover Lithium from brine solutions.

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President at 1.250.765.6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its technology, mining projects, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. There can be no assurance that the brine recovery system will be effective for the recovery of Lithium and if effective will be economic or have any positive impact on Enertopia. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: Enertopia Corporation

ReleaseID: 453852

KELOWNA, BC / ACCESSWIRE / January 31, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is currently being featured on CEO Clips airing on BNN. CEO Clips profiles some of the most innovative publicly traded companies in North America and is currently featuring a 15 second clip about Lexaria. The clip can also be viewed online via this link: http://www.b-tv.com/lexaria-commercial/.

BTV has also produced a CEO clip with Company President, John Docherty introducing Lexaria’s technology. The clip can be viewed at http://www.b-tv.com/lexaria-ceo-clip/ and has also been posted on the Thomson Reuters Insider Network where it can be viewed by over 80,000 financial professionals at http://reut.rs/2kc0Ewn.

Lexaria has separately engaged SJF Communications for a 3-month social media campaign designed to distribute Lexaria’s information to as wide a network as possible. SJF Communications owns @CanadaPotStocks and is a top influencer with over 18,000 followers on Twitter and is considered a leading source for information & opportunity in the emerging legal cannabis sector.

Lexaria’s unique patented technology allows for more efficient and effective absorption of certain molecules such as cannabinoids, while simultaneously masking and at times even eliminating inherent strong flavours and/or odors typical of those molecules. Lexaria’s technology is extremely cost effective to implement and applicable to the widest imaginable spectrum of foods.

About Lexaria

Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. The Company’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com

About BNN

Business News Network (BNN) is Canada’s only all business specialty channel with real time coverage of global market activity from a Canadian perspective.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the recent license agreement, hemp oil sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors or as a result of the license agreement. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements, nor that Lexaria’s technology will deliver any improvement in taste or bioavailability with any reliability nor across any product category. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any hemp oil or cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever, nor that any patent application in the USA or any other nation or under any treaty will result in the award of an actual patent; nor that an award of any actual patent will protect against challenges from unknown third parties. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: Lexaria Bioscience Corp.

ReleaseID: 453869

SEATTLE, WA / ACCESSWIRE / January 31, 2017 / SinglePoint, Inc. (OTC PINK: SING), a full-service mobile technology and marketing provider, is entering an exciting niche of the cannabis industry through a Letter of Intent (“LOI”) to acquire an interest in Jacksam Corp., dba Convectium, a profitable California-based provider of equipment, branding, and packaging solutions for the cannabis industry.

Convectium is the creator of the world’s first oil filling machine focused on the cannabis industry that is capable of filling cartridges or disposable vape pens for wholesale distribution to dispensaries. The company’s 710Shark and 710Seal system can fill and package up 100+ cartridges or disposable vape pens in 30 seconds, making it the fastest filling and sealing system of its kind.

Convectium operates a B2B equipment division in addition to its legacy B2C products. The proprietary equipment is solely distributed by EquipCanna.com, the Convectium B2B brand. Based on its market position and increasing demand for its products and services, Convectium forecasts revenues for 2017 at $3.5 million, an increase of 150% compared to revenue of $1.4 million for 2016.

Convectium ships its consumer brands to over 52 countries. The company’s line of B2C brands include BlackoutX as well as HazeSticks, inspired by the Jimi Hendrix Cannabis Collection.

“To say we are excited about this opportunity is an understatement,” states SinglePoint CEO, Greg Lambrecht. “Convectium’s 710Shark and 710Seal system is incredible, and its capabilities are unmatched. After looking at hundreds of cannabis companies, finding an acquisition opportunity like we have found in Convecitum adds a new dynamic to our endeavors and the cannabis industry as a whole.”

Per the LOI, SinglePoint will pay Jacksam a stock and cash consideration totaling $800,000. The transaction is expected to accelerate SinglePoint’s existing presence in the cannabis industry – established by its SingleSeed subsidiary – while creating another avenue of participation in the “Green Rush” of the multi-billion dollar cannabis industry.

“We are excited to enter into an agreement with SinglePoint, one of the leading and most visionary publicly traded cannabis companies in the market. Paired with our proprietary technology and commitment to the future of the infrastructure of the cannabis industry, Convectium and SinglePoint are creating a unique business dynamic with incredible potential,” says Danny Davis, managing partner at Convectium.

A definitive agreement on the announced transaction is expected no later than May 24, 2017, subject to certain terms and conditions, the completion of due-diligence and obtaining the required consents and regulatory approvals. Upon closing the transaction Convectium will become a subsidiary of Singlepoint.

About SinglePoint, Inc.

SinglePoint, Inc. is a full-service mobile technology and marketing provider. The company provides solutions that allow its clients to conduct business transactions, accept donations, and engage in targeted communication through mobile devices. SinglePoint products connect small to mid-size companies to their target markets by providing innovative mobile technology at reasonable rates. SinglePoint recognized the strength in acquiring interest in undervalued subsidiaries in other markets, such as Daily Fantasy Sports, to create a diversified holding base.

Connect on social media at: www.facebook.com/SinglePointMobile, www.twitter.com/_SinglePoint_, www.linkedin.com/company/SinglePoint and www.youtube.com/user/SinglePointMobile

For more information visit www.SinglePoint.com.

About Jacksam Corp. dba Convectium

Convectium was founded in October of 2013 and based in South Orange County, California. Convecitum does not touch plants; its branding, packaging and equipment solutions help grow the companies that do. With the industry’s first and only oil filling system, proprietary packaging systems and innovative devices, Convectium represents a commitment to the future of infrastructure in the cannabis industry.

See the 710Shark at work here: https://vimeo.com/169612830

For more information visit www.Convectium.com, www.BlackoutX.com or www.710Shark.com.

Forward-Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Contact:

SinglePoint, Inc.

Greg Lambrecht

602-481-1544

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

SOURCE: SinglePoint, Inc.

ReleaseID: 453847